Manulife (Manufacturers Life Insurance)
MACK

Manulife (Manufacturers Life Insurance)’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-836
Closed -$3K – 4304
2018
Q2 		$3K Sell
836
-10,701
-93% -$71.1K ﹤0.01% 4188
2018
Q1 		$73K Buy
11,537
+7,695
+200% +$63.7K ﹤0.01% 3485
2017
Q4 		$31K Sell
3,842
-10,682
-74% -$99.6K ﹤0.01% 3682
2017
Q3 		$166K Buy
14,524
+132
+0.9% +$1.39K ﹤0.01% 3124
2017
Q2 		$141K Buy
14,392
+1,854
+15% +$37.9K ﹤0.01% 3250
2017
Q1 		$304K Buy
12,538
+1,719
+16% +$43K ﹤0.01% 2539
2016
Q4 		$347K Buy
10,819
+71
+0.7% +$3.03K ﹤0.01% 2372
2016
Q3 		$537K Buy
10,748
+188
+2% +$7.8K ﹤0.01% 2036
2016
Q2 		$448K Buy
10,560
+835
+9% +$45.5K ﹤0.01% 2106
2016
Q1 		$623K Buy
9,725
+668
+7% +$34.9K ﹤0.01% 1854
2015
Q4 		$563 Hold
9,057
– – ﹤0.01% 1952
2015
Q3 		$606 Buy
9,057
+245
+3% +$20K ﹤0.01% 1878
2015
Q2 		$857 Buy
8,812
+563
+7% +$53.6K ﹤0.01% 1778
2015
Q1 		$771 Buy
8,249
+300
+4% +$25.5K ﹤0.01% 1821
2014
Q4 		$707 Sell
7,949
-286
-3% -$20.8K ﹤0.01% 1782
2014
Q3 		$569 Buy
8,235
+221
+3% +$11.8K ﹤0.01% 1909
2014
Q2 		$460K Sell
8,014
-1,434
-15% -$72.8K ﹤0.01% 2092
2014
Q1 		$374 Sell
9,448
-307
-3% -$13.1K ﹤0.01% 2278
2013
Q4 		$410 Buy
9,755
+691
+8% +$20K ﹤0.01% 2191
2013
Q3 		$271 Sell
9,064
-405
-4% -$14.2K ﹤0.01% 2426
2013
Q2 		$501K Buy
+9,469
New +$415K ﹤0.01% 1894

Other funds holding MACK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s MACK Position: Q3 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2018, closing a stake of 836 shares — an estimated $3K sold.

Manulife (Manufacturers Life Insurance) first reported a position in MACK in Q2 2013 and held it in 21 quarters. The position peaked at $623K in Q1 2016. 63 funds tracked by Wall St. Rank hold MACK as of Q3 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 836 Merrimack Pharmaceuticals, Inc. shares in Q3 2018, an estimated $3K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 21 quarters.
  • Manulife (Manufacturers Life Insurance)'s Merrimack Pharmaceuticals, Inc. position peaked at $623K in Q1 2016.
  • 63 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2018, filed 14 Nov 2018.